TOP NEWS: GlaxoSmithKline Gets EU Approval For Wider Relvar Drug Use
8th Mar 2018 08:10
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday its asthma and chronic obstructive pulmonary disease drug Relvar Ellipta has received a "positive" EU with Read More